P62. Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide (TEC)
DC Element | Wert | Sprache |
---|---|---|
dc.contributor.author | Vogt, Ulrich | |
dc.contributor.author | Schlotter, C. M. | |
dc.contributor.author | Bosse, U. | |
dc.contributor.author | Bonk, Ulrich | |
dc.contributor.author | Brandt, Burkhard | |
dc.date.accessioned | 2023-07-11T11:28:24Z | - |
dc.date.available | 2023-07-11T11:28:24Z | - |
dc.date.issued | 2006 | |
dc.identifier.uri | http://osnascholar.ub.uni-osnabrueck.de/handle/unios/70327 | - |
dc.subject | Medicine | |
dc.subject | Neoadjuvant therapy | |
dc.subject | Cyclophosphamide | |
dc.subject | Chemotherapy | |
dc.subject | Internal medicine | |
dc.subject | Docetaxel | |
dc.subject | Oncology | |
dc.subject | Breast cancer | |
dc.subject | Epirubicin | |
dc.subject | Cancer | |
dc.title | P62. Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide (TEC) | |
dc.type | journal article | |
dc.identifier.doi | https://doi.org/10.1016/j.ejcsup.2006.04.122 | |
dc.description.volume | 4 | |
dc.description.issue | 6 | |
dc.description.startpage | 49 | |
dc.description.endpage | 50 | |
dc.identifier.external | https://openalex.org/W2063775184 | |
dcterms.oaStatus | true | |
local.import.sourcefile | openalex_20230710.ris | |
local.rawaffiliation | null |
Seitenaufrufe
1
Letzte Woche
1
1
Letzter Monat
1
1
geprüft am 09.06.2024